2936-99-4 Usage
Also known as
Tryptamine acetate
Type
Chemical compound and derivative of tryptamine
Relation
Structurally related to the neurotransmitter serotonin
Psychoactive effects
Potential for hallucinogenic effects
Mental health and cognitive function
Possible role in mental health and cognitive function
Organic chemistry use
Used as a starting material for the synthesis of various other compounds
Therapeutic applications
Research into potential treatment of neurological and psychiatric disorders
Molecular mechanisms
Role in understanding the molecular mechanisms of brain function
Psychoactive research
Focused on understanding the potential effects and risks of using tryptamine acetate
Mental health connection
Examining the possible influence on cognitive function and mental health conditions
Synthesis applications
Utilized as a starting material to create a variety of complex organic compounds
Therapeutic potential
Investigating the possible benefits in treating neurological and psychiatric disorders
Brain function understanding
Contributing to the knowledge of how the brain functions at a molecular level
Check Digit Verification of cas no
The CAS Registry Mumber 2936-99-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,9,3 and 6 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2936-99:
(6*2)+(5*9)+(4*3)+(3*6)+(2*9)+(1*9)=114
114 % 10 = 4
So 2936-99-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2.C2H4O2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10;1-2(3)4/h1-4,7,12H,5-6,11H2;1H3,(H,3,4)
2936-99-4Relevant articles and documents
A Concise, Enantioselective Approach for the Synthesis of Yohimbine Alkaloids
Miller, Eric R.,Hovey, M. Todd,Scheidt, Karl A.
supporting information, p. 2187 - 2192 (2020/02/04)
We report a concise, enantioselective synthesis of the yohimbine alkaloids (-)-rauwolscine and (-)-alloyohimbane. The key transformation involves a highly enantio- and diastereoselective NHC-catalyzed dimerization and an amidation/N-acyliminium ion cyclization sequence to furnish four of the five requisite rings and three of the five stereocenters in two operations. This route also provides efficient access to all four diastereomeric arrangements of the core stereotriad of the yohimbine alkaloids from a common intermediate. This platform approach in combination with the ability to access both enantiomers from the carbene-catalyzed reaction is a powerful strategy that can produce a wide range of complex alkaloids and related structures for future biomedical investigations.
